USP6NL and glioblastoma: An increase in the apoptosis of the shUSP6NL group was also observed, providing strong evidence for the key role of USP6NL in targeting GBM-TMZ resistance and highlighting the possibility of subsequent human-targeted therapy research related to USP6NL.